Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin vs Norepinephrine for Intestinal Function in Septic Shock
NCT02306239Unknown
- Start
- Dec 2014
- Primary completion
- Aug 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of terlipressin in septic shock (2 arms). Primary endpoint: Intestinal function assessed by abdominal distension, intestinal bleeding, peritonitis, plasma DAO level, enteral nutrition at 7 days. Status: unknown.
02
Drugs
terlipressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02306239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306239.